A randomized controlled phase II clinical trial on mRNA electroporated autologous dendritic cells for stage III/IV melanoma patients who are disease-free following the local treatment of macrometastases

Category Primary study
JournalCANCER IMMUNOLOGY RESEARCH
Year 2016
This article has no abstract
Epistemonikos ID: 3d856bcc44b82f157efcda92cc3fb4ff9ab19044
First added on: Feb 08, 2025